PBH

Prestige Consumer HealthcareA

NYSE / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

AI scenario view

RankAlpha Sentiment Codex

B+

Bull case

25%

Probability

Target price

$67.25

Analysis reference price unavailable

Analysis 2026-09-10 · RankAlpha Sentiment Codex

Most likely

Base case

50%

Probability

Target price

$54.00

Analysis reference price unavailable

Analysis 2026-09-10 · RankAlpha Sentiment Codex

B-

Bear case

25%

Probability

Target price

$43.00

Analysis reference price unavailable

Analysis 2026-09-10 · RankAlpha Sentiment Codex

The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented

AI sentiment snapshot

Latest data as of 2026-09-10

AI commentary

News tone is constructive following the Q1 beat, raised outlook, acquisitions, and record adjusted free cash flow. Social, options, short-interest, employee-sentiment, post-print market-reaction, and analyst-revision data are unavailable or insufficient in the packet, so this remains a cautious monitoring view rather than a high-conviction rerating call.

RankAlpha Sentiment Codex - 2026-09-10

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-08-06eventQ1 FY2027 beat and raised outlookMedium impact

Q1 revenue increased 6.5% to $265.7 million, organic sales grew 3.2%, adjusted EPS was $0.98, adjusted free cash flow reached $83.7 million, and management raised fiscal 2027 revenue and adjusted EPS guidance. [#SEC-8K-2026-08-06]

2026-08-14catalystOperations leadership transitionMedium impact

The Senior Vice President of Operations retired effective August 14, 2026. The filing does not identify operational disruption, but the transition warrants near-term execution monitoring. [#8-K-2026-08-14]

2027-03-31catalystAcquisition integration and deleveragingHigh impact

Breathe Right and LaCorium expand the portfolio, while approximately $2 billion of net debt makes integration execution, free-cash-flow conversion, and deleveraging the key medium-term drivers. [#SEC-8K-2026-08-06]

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-09-10 • Updated nightlySource: Internal modelMethodology